Scientific Advisors
Kidney cancer research is a fast-moving space. The following Advisory Board members provide guidance and ensure we stay up-to-date.
“Kidney cancer is the ideal sandbox for new approaches, and without a doubt these approaches can, should, and will be suitable for other cancers.”
Dr. Hans Hammers
Mehmet Bilen, MD
Assistant Professor, Department of Hematology and Medical Oncology, Emory University School of Medicine.
Director, Genitourinary Medical Oncology Program, Winship Cancer Institute of Emory University.
Associate Medical Director, Phase I Unit,
Winship Cancer Institute of Emory University
Director, Genitourinary Medical Oncology Program, Winship Cancer Institute of Emory University.
Associate Medical Director, Phase I Unit,
Winship Cancer Institute of Emory University
Gennady Bratslavsky, MD
Professor and Chair of Urology Professor of Biochemistry and Molecular Biology Division Chief of Upstate Urology at 550 Harrison Division Chief of Urologic Male Health Director of Prostate Cancer Program Department Chief of Adult Urology Clinic Department Chief of Urologic Oncology
James Brugarolas, MD, PhD
Professor of Internal Medicine, Cancer Biology, Genetics, Development and Disease. The founding Director of the Kidney Cancer Program at UT Southwestern Simmons Cancer Center and Principal Investigator of one of two Specialized Programs of Research Excellence (SPORE) in kidney cancer in the U.S.
Toni Choueiri, MD
Director of the Lank Center for Genitourinary (GU) Oncology at Dana-Farber Cancer Institute/Brigham and Women’s Hospital and the Jerome and Nancy Kohlberg Chair and Professor of Medicine at Harvard Medical School.
Rachel Giles, MD
Staff, Internal Medicine Dept. Nephrology and Hypertension
University Medical Center Utrecht, The Netherlands
Chair – IKCC Board
University Medical Center Utrecht, The Netherlands
Chair – IKCC Board
Hans Hammers, MD, PHD
Associate Professor of Internal Medicine in the Division of Hematology-Oncology at UT Southwestern Medical Center. Co-leader of clinical research of the Kidney Cancer Program at Simmons Cancer Center.
Eric Jonasch, MD
Professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Payal Kapur, MD
Dr. Kapur is on faculty in the Department of Pathology and Urology at UT Southwestern and the Group Leader of Genitourinary Pathology and the Co-Leader of the Kidney Cancer Program at Simmons Cancer Center.
Marc Michaelson, MD, PhD
Director, Massachusetts General Hospital Hematology/Oncology Fellowship Program
Mehdi Mollapour, PhD
Professor, Vice Chair for Translational Research and Director of Renal Cancer Biology Program for the Department of Urology. Adjunct Professor at the Department of Biochemistry and Molecular Biology at SUNY Upstate Medical University.
Eric Singer, MD, MA, FACS
Associate Chief of Urology
Director, Kidney Cancer Program
Rutgers Cancer Institute of New Jersey
Associate Professor of Surgery and Radiology
Ramaprasad Srinivasan, MD, PHD
Investigator Urologic Oncology Branch Head, Molecular Cancer Therapeutics Section NCI
KCRS is an annual meeting focused on basic, translational, and clinical kidney cancer research. The meeting is fueled by the ideas and research funded through the Department of Defense CDMRP-KCRP awards.
The goal for KCRS is to present the important, innovative research funded by the KCRP. We also aim to connect researchers from around the world to share their work.
KCRS22 WILL BE HELD ON OCTOBER 6-7, 2022
